Lebwohl, Mark G. http://orcid.org/0000-0002-4705-5303
Koo, John Y. http://orcid.org/0009-0004-1005-5221
Armstrong, April W. http://orcid.org/0000-0002-6892-6286
Strober, Bruce E. http://orcid.org/0000-0002-8394-2057
Martin, George M. http://orcid.org/0000-0002-8197-0740
Rawnsley, Nicole N. http://orcid.org/0009-0005-7856-6615
Goehring, Earl L. Jr. http://orcid.org/0000-0002-3935-8355
Jacobson, Abby A. http://orcid.org/0000-0002-7810-2280
Funding for this research was provided by:
Ortho Dermatologics
Article History
Received: 31 January 2024
Accepted: 8 April 2024
First Online: 9 May 2024
Declarations
:
: Mark G. Lebwohl is an employee of Mount Sinai; has received research funds from AbbVie, Amgen, Arcutis, Avotres, Boehringer Ingelheim, Cara Therapeutics, Dermavant Sciences, Eli Lilly, Incyte, Inozyme, Janssen Research & Development, Ortho Dermatologics, Pfizer, Sanofi-Regeneron, and UCB; and has been a consultant for Almirall, AltruBio, AnaptysBio, Arcutis, AstraZeneca, Avotres Therapeutics, Brickell Biotech, Boehringer Ingelheim, Bristol-Myers Squibb, Castle Biosciences, Celltrion, CorEvitas, Dermavant Sciences, EPI, Evommune, Facilitation of International Dermatology Education, Forte Biosciences, Foundation for Research and Education in Dermatology, Galderma, Genentech, Incyte, LEO Pharma, Meiji Seika Pharma, Mindera, Pfizer, Seanergy, Strata, Trevi, and Verrica. John Y. Koo has been a consultant or speaker for AbbVie, Amgen, Eli Lilly, EPI, Janssen, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, and Sun Pharmaceutical. April W. Armstrong has served as a research investigator for and/or scientific advisor to AbbVie, Almirall, Arcutis, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant Sciences, Dermira, EPI, Incyte, Janssen, LEO Pharma, Lilly, Mindera, Nimbus, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharmaceutical, and UCB. Bruce E. Strober has been an investigator, scientific director, consultant, or member of a speakers bureau or advisory board for AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Celgene, CorEvitas Psoriasis Patient Registry, Cutanea-Maruho, Dermira, Eli Lilly, GlaxoSmithKline, Janssen, LEO Pharma, Medac Pharma, Novartis, Pfizer, Sun Pharmaceutical, and UCB; has received grant support for a fellowship program from AbbVie and Janssen; and has received investigational/grant support payments for the University of Connecticut. George M. Martin has served as a consultant, speaker, or scientific advisory board member for AbbVie, Almirall, Alumis, Bristol-Myers Squibb, Celgene, Dermavant, DUSA/Sun Pharmaceutical, Eli Lilly, Evelo, Galderma, Horizon, Incyte, Janssen, LEO Pharma, Nobelpharma, Organogenesis, Ortho Dermatologics, Pfizer, Trevi Therapeutics, and UCB. Nicole N. Rawnsley, Earl L. Goehring Jr, and Abby A. Jacobson are employees of Bausch Health Companies Inc.
: Ethics approval and informed consent were not required, as the postmarketing data summarized in this report were noninterventional and were not collected as part of a clinical study.